GlassScriptPhysician profile
Eileen M Mcdonnell
NPI 1942597828
$58,457.72
in general payments reported to CMS, 2019-2025
13 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $12K · 2023: $19K · 2024: $1,035 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $2,274 · Travel and Lodging: $1,400 · Consulting Fee: $900 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,800.00 |
| Food and Beverage | $2,273.68 |
| Travel and Lodging | $1,400.04 |
| Consulting Fee | $900.00 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $57,744.98 | 2021-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.07 | 2023 | Ofev |
| Aurinia Pharma U.S., INC. | $100.93 | 2023 | Lupkynis |
| United Therapeutics Corporation | $89.73 | 2023 | |
| Ani Pharmaceuticals, INC. | $55.07 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $33.78 | 2025 | Cresemba |
| Advanced Respiratory, INC | $33.00 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $24.79 | 2024 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $22.05 | 2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $18.45 | 2023 | |
| Paratek Pharmaceuticals, INC. | $18.00 | 2022 | |
| Insmed, INC. | $15.41 | 2021 | |
| Electromed, INC. | $14.46 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Mcdonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.